BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


November Archive 2003 - have your press release here?

Syncroscopy Major Insect Imaging Project at Harvard Chooses Auto-Montage to Create International Species Standards 

SBH Sciences: Unique Cell-based Bioassay Services (Updated).

OXFORD BIOMEDICA SECURES FUNDING FROM THE FOUNDATION FIGHTING BLINDNESS FOR ITS RETINOSTAT(TM) PRODUCT FOR VISION-LOSS

Catachem Introduces the Total Bile Acids (TBA) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit

Biotech Tracker: MDX-060 Data at ASH

Vernalis plc: Research and Development Update

Vernalis plc: Integration Update

Northbank Communications Account Manager Awarded MBA

SBH Sciences: Unique Cell-based Bioassay Services.

Catachem Announces the Introduction of the Lithium (Li) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit.

Anti-hypertensives: Landmark study data to drive sales

Generics: FDA initiative to speed up introduction of generic drugs faces opposition

ALS: a disease without a treatment?

BioTech Stock Report today announced the release of its December 2003 issue. 

Catachem Announces the Introduction of the Potassium (K) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit.

Inpharmatica Biopendium[TM] subscription with Aventis

GM Crops can and should Co-Exist in the UK: It’s time to give UK consumers and farmers the right to choose

GLAXOSMITHKLINE ENGAGES BIOWISDOM IN SECOND AGREEMENT FOR ONTOLOGY

Co-existence of GM and non GM crops in the UK can occur without problems, says new research paper

Catachem Announces the Introduction of the Sodium (NA) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit.

Catachem Announces the Introduction of the Pre-Albumin (TBPA) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit

Biotech Tracker: Exanta Excitement Builds

Biotech Tracker: Pralnacasan Trial Suspended

FIRST PRION REDUCTION PRODUCT PRESENTED AT THE EUROPEAN PLASMA FRACTIONATION ASSOCIATION CONFERENCE

SCYNEXIS and GeneCare Research Institute sign anti-inflammatory drug discovery deal 

Proteome Systems awarded prestigious Technology Innovation Award

ImmunoBiology raises further finance for developing influenza vaccines 

Archemix and Regado Announce License Agreement for Antidote-Controlled Aptamers

Agilent Technologies Returns to Profitability in Fourth Quarter 2003 Company Exceeds Fourth-Quarter Expectations 

Survey of out-licensing biotech companies reveals Bristol-Myers Squibb perceived to be the best company to deal with, Abbott perceived to be the worst

Biotech Tracker: Exanta Continues to Move Forward

SWITCH Biotech AG First Clinical Results in the Treatment of Psoriasis

Chemical Computing Group announces Excellence Awards for ACS

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP plc (CAT) PRELIMINARY STATEMENT OF RESULTS 

Rubicon Genomics, Inc. today announced the launch of their GenomePlex™ whole genome amplification (WGA) point of use kit 

Icon Genetics and Novoplant announce broad license agreement

Synbiosis - New Colony Counting Study Shows ĺCOLyte SuperCount Matches Manual Counting for Accuracy 

BioZak InfoBase Inc. Announces Partnership with BioPortfolio.com.

OXFORD BIOMEDICA REPORTS PROMISING PRECLINICAL RESULTS WITH MONUDIN IN THE TREATMENT OF MOTOR NEURON DISEASE

New DigiGenius5 Imaging System Offers Affordable and Accurate Gel Documentation

Biotech Tracker: High Quality Studies Support Use of Arixtra and Approval of Exanta

Biotech Tracker: LymphoStat-B On Track

Biotech Tracker: Riquent and LJP 1082 Presentations at ACR

BiotechTracker: ACR Data Support Continued ISIS 104838 Development

DR. DAVID OSBORNE PRESENTS PERFLUORINATED SURFACTANTS AS SKIN PENETRATION ENHANCERS AT AMERICAN CHEMICAL SOCIETY NATIONAL MEETING   

Biotech Tracker: LymphoStat-B On Track

BioTech Stock Report today announced the release of its November 2003 issue

Agilent Technologies Introduces Flexible Software Solutions for Preparative HPLC

Life Sciences CEO & Investor Forum Slated for March 22 – 23, 2004

Paradigm Therapeutics Limited announces the incorporation of a new subsidiary in Singapore

Biotech Tracker: Xyotax Limited to Lower Dose in Phase III Studies 

Biotech Tracker: Lexiva Approved

Biotech Tracker: Merimepodib Will Not Replace Ribavirin

Serzone: New safety concerns ensures continued focus on antidepressants

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) ANNOUNCES MANAGEMENT APPOINTMENTS

Spectrophotometers for all 

3i says Healthcare CEOs optimistic - Investment in Healthcare Market to Take Off Again in 2004

New Application of GeneGenius Is Helping to Identify Druggable Targets to Repair Spinal Injuries

November 2003 Archive

October 2003 Archive

September 2003 Archive

July/August 2003 Archive

June 2003 Archive

May 2003 Archive

March/April 2003 Archive

February 2003 Archive

January 2003 Archive

December Archive

November Archive

October Archive

September Archive

August Archive

July Archive

June Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.